The incidence of malignant mesothelioma has increased greatly in the last 40 years. Current and recent past exposure to asbestos is expected to substantially increase this incidence. We report nine cases of malignant mesothelioma which temporarily responded to treatment with high-dose methotrexate-c
β¦ LIBER β¦
Assay for methotrexate in nanomolar concentrations with simultaneous detection of citrovorum factor and vincristine
β Scribed by William M. Deen; Peter F. Levy; James Wei; Randall D. Partridge
- Publisher
- Elsevier Science
- Year
- 1981
- Tongue
- English
- Weight
- 499 KB
- Volume
- 114
- Category
- Article
- ISSN
- 0003-2697
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
High-dose methotrexate with citrovorum f
β
Nikolay V. Dimitrov; James Egner; Ernie Balcueva; Leif G. Suhrland
π
Article
π
1982
π
John Wiley and Sons
π
English
β 272 KB
π 3 views
Combined chemotherapy with carmustine, d
β
Luigi Rigacci; Valentina Carrai; Luca Nassi; Renato Alterini; Giovanni Longo; Fr
π
Article
π
2005
π
John Wiley and Sons
π
English
β 119 KB
π 1 views
A validated HPLC method with electrochem
β
Giancarlo Palumbo; Simona Bacchi; Luisa Primavera; Paola Palumbo; Giuseppe Carlu
π
Article
π
2005
π
John Wiley and Sons
π
English
β 120 KB
π 2 views
Detection of epidermal growth factor rec
β
Chen He; Ming Liu; Chengzhi Zhou; Jiexia Zhang; Ming Ouyang; Nanshan Zhong; Jun
π
Article
π
2009
π
John Wiley and Sons
π
French
β 260 KB
π 2 views
## Abstract The high frequency of epidermal growth factor receptor (__EGFR__) mutations in tyrosine kinase inhibitorβresponsive nonβsmallβcell lung cancer (NSCLC) cases is now well established, highlighting the predictive value of activating __EGFR__ mutations in guiding the clinical use of __EGFR_